What is CV's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.35B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CV?

P/E (TTM) is n/a and 52-week range is $4.38 to $15.37 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CV figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CV?

The company profile lists revenue (TTM) near $14M, net income (TTM) near $-2.98B, EPS (TTM) near $-0.63 when available from the market-data feed. Figures are informational and may lag live markets.

Where is CapsoVision Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Saratoga California, California, US, 50M shares outstanding, ISIN US1409351079 when available from company profile and filing metadata.

CapsoVision Inc

$CV

Health Care · Health Care Equipment & Supplies

Run Scenarios

$6.59

-0.45%

CapsoVision Inc

$CV

Health Care · Health Care Equipment & Supplies

Run Scenarios

$6.59

-0.45%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

Employees

99

Website

www.capsovision.com/

IPO

2025-07-02

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US1409351079

Headquarters

Saratoga California, California, US

Shares outstanding

50M

NAICS sector

Manufacturing

Institutional ownership

10.35%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

Employees

99

Website

www.capsovision.com/

IPO

2025-07-02

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)